Monday, September 14, 2026

SANDRO Dual 2026: The Next Big Thing in Laser Hair Removal Approved by Japan and Taiwan

Wontech's SANDRO Dual 2026 laser device gains certifications in Japan and Taiwan, enhancing its global market presence in cosmetic procedures.

Kim Yo-jong’s Rise: What Does Her New Role Mean for North Korea’s Foreign Policy?

Kim Yo-jong's promotion in North Korea signals a shift in external strategy, with potential oversight of inter-Korean affairs and diplomatic initiatives.

BLACKPINK Lisa Returns with New Hit ‘New Woman’ Featuring Rosalía

Lisa announced yesterday afternoon that her new song, "NEW WOMAN," will be released on LLOUD Co.'s official website.

Tag: obesity

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Novo Nordisk Launches Clinical Trials for Next-Gen Obesity Drug ZenaGamtide in Asia: What to Expect?

Novo Nordisk begins domestic Phase 3 trials for obesity treatment candidate ZenaGamtide, competing with Eli Lilly's market leader.

Revolutionizing Obesity Treatment: Hanmi Pharmaceutical’s Digital Fusion Drug EPPE Launching in 2026

Hanmi Pharmaceutical is developing digital therapeutics by combining obesity treatment 'Efe' with digital technology.

“Last Hope Was Korea”…Korean Liver Transplant Team Saves Patient With Advanced Liver Cancer [K-Medical Report]

A Moroccan patient with advanced liver cancer and end-stage liver failure, deemed inoperable overseas, underwent a complex 17-hour two-donor living-donor liver transplant at Asan Medical Center and survived

How Hanmi Pharmaceutical’s AI Platform is Revolutionizing Obesity Drug Development in 2026

Hanmi Pharmaceutical leverages AI for drug discovery, developing innovative obesity treatments and advancing to clinical trials.

Novo Nordisk vs Eli Lilly: Is Weight Loss Advertising Misleading?

Novo Nordisk sues Eli Lilly for misleading ads on obesity drugs, claiming false comparisons and seeking corrective action in court.

How Salidroside from Korean Ginseng Can Combat Insulin Resistance and Prevent Diabetes

Research reveals salicin from tianma improves insulin resistance, aiding diabetes prevention and intestinal health restoration.

Smoking Raises Fatty Liver Risk by Up to 1.5 Times Among Young Adults

Young adult smokers face a higher risk of fatty liver disease, with significant findings on its impact regardless of obesity or alcohol consumption.

Can GLP-1 Medications Reduce Breast Cancer Risk? New Research Reveals Surprising Findings

GLP-1 drugs show promise in cancer prevention and progression inhibition, expanding beyond obesity treatment to chronic disease management.

AstraZeneca’s Elecoglipron: Can This New Weight Loss Pill Compete with GLP-1 Giants?

AstraZeneca's new weight-loss pill, elecoglipron, shows promising results in trials, competing with existing obesity treatments.

Inventage Lab Secures Patent for Semaglutide Formulation Aimed at Improving Oral Bioavailability

Inventage Lab secures a patent for a liposome formulation enhancing semaglutide's bioavailability, aiming to lead in obesity treatment.

Novo Nordisk’s Oral Wegovy Just Put Up a Number That Could Change the Obesity Drug Race

Novo Nordisk's oral obesity treatment, Wegovy, saw $400M in Q1 2026 sales, exceeding estimates and indicating strong market demand.

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.